Authors: Alves-Rodrigues, A Lemstra, S Vollinga, RC Menge, WMPB Timmerman, H Leurs, R

Citation: A. Alves-rodrigues et al., Pharmacological analysis of immepip and imetit homologues. Further evidence for histamine H-3 receptor heterogeneity?, BEH BRA RES, 124(2), 2001, pp. 121-127

Authors: van Muijlwijk-Koezen, JE Timmerman, H Vollinga, RC Kunzel, JFV de Groote, M Visser, S Ijzerman, AP

Citation: Je. Van Muijlwijk-koezen et al., Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists, J MED CHEM, 44(5), 2001, pp. 749-762

Authors: de Zwart, M Vollinga, RC Beukers, MW Sleegers, DF Kunzel, JKVD de Groote, M Ijzerman, AP

Citation: M. De Zwart et al., Potent antagonists for the human adenosine A(2B) receptor. Derivatives of the triazolotriazine adenosine receptor antagonist ZM241385 with high affinity, DRUG DEV R, 48(3), 1999, pp. 95-103

Authors: van Tilburg, EW Kunzel, JVD de Groote, M Vollinga, RC Lorenzen, A IJzerman, AP

Citation: Ew. Van Tilburg et al., N-6,5 '-disubstituted adenosine derivatives as partial agonists for the human adenosine A(3) receptor, J MED CHEM, 42(8), 1999, pp. 1393-1400

Authors: De Esch, IJP Vollinga, RC Goubitz, K Schenk, H Appelberg, U Hacksell, U Lemstra, S Zuiderveld, OP Hoffmann, M Leurs, R Menge, WMPB Timmerman, H

Citation: Ijp. De Esch et al., Characterization of the binding site of the histamine H-3 receptor. 1. Various approaches to the synthesis of 2-(1H-imidazol-4-yl)cyclopropylamine and histaminergic activity of (1R,2R)- and (1S,2S)-2-(1H-imidazol-4-yl)cyclopropylamine, J MED CHEM, 42(7), 1999, pp. 1115-1122

Authors: Borg, S Vollinga, RC Labarre, M Payza, K Terenius, L Luthman, K

Citation: S. Borg et al., Design, synthesis, and evaluation of Phe-Gly mimetics: Heterocyclic building blocks for pseudopeptides, J MED CHEM, 42(21), 1999, pp. 4331-4342